Please login to the form below

Not currently logged in
Email:
Password:

anti-infectives

This page shows the latest anti-infectives news and features for those working in and with pharma, biotech and healthcare.

Sanofi taps Evotec for new anti-infectives drive

Sanofi taps Evotec for new anti-infectives drive

the progress of novel anti-infectives on Evotec’s platform will be a key success factor”. ... Research in the field of anti-infectives is an area where building critical mass through partnering is particularly important.”.

Latest news

More from news
Approximately 2 fully matching, plus 54 partially matching documents found.

Latest Intelligence

  • Deal Watch May 2016 Deal Watch May 2016

    Not only but also…. To close this month a recent report from the UK government expresses concerns about the lack of investment in anti-infectives R&D.

  • Another lost decade for research? Another lost decade for research?

    use but new classes of antibiotics - as well as non-antibiotic approaches such as other anti-infective treatments. ... Over the past 10 years the number of patent families filed in the antibiotics and anti-infectives field has remained stable, with

  • Pharma deals in June 2015 Pharma deals in June 2015

    The month of June saw a mixture of deals covering a wide range of therapeutic areas, including aesthetic medicine, CNS, diabetes, respiratory, vaccines and anti-infectives, oncology and autoimmune diseases. ... The consequences of acquisitions. One of

  • Pharma deals in February 2015 Pharma deals in February 2015

    Hospira's broad generic sterile injectables business covers acute care and oncology which compliments Pfizer's branded sterile injectables covering anti-infectives, anti-inflammatories and cytotoxics.

  • Cubist: Meeting the challenge in antibiotics Cubist: Meeting the challenge in antibiotics

    Cubist: Meeting the challenge in antibiotics. Patrick Vink on Cubist Pharmaceuticals’ ambitions in anti-infectives, which have attracted the attention of Merck &Co. ... We are in desperate need of new anti-infectives. Only a few products have been

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Damien McDevitt moves from GSK to Acadia Pharmaceuticals Damien McDevitt moves from GSK to Acadia Pharmaceuticals

    Prior to that, McDevitt held positions with increasing responsibility within worldwide business development at GSK Ventures and Anti-Infectives Discovery.

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Lavino joins the Austrian clinical-stage biopharma firm from Merck &Co (MSD), bringing nearly two decades of pharmaceutical sales and marketing experience with expertise in anti-infective medications. ... Prior to serving MSD as its acting vice president,

  • Cidara Therapeutics makes senior appointments Cidara Therapeutics makes senior appointments

    Prior to BMS, Daruwala spent 18 years at Merck in a range of US and global commercial leadership roles in areas including anti-inflammatory products, business development and sales management. ... Cidara focuses on the discovery, development and

  • Xellia forms scientific advisory board Xellia forms scientific advisory board

    Xellia forms scientific advisory board. Will further progress on innovative anti-infectives. ... Xellia Pharmaceuticals, who have a focus on anti-infective treatments, has announced the formation of a new scientific advisory board.

  • Melinta names chief medical officer Melinta names chief medical officer

    She has prior experience in developing anti-infectives, including Cubicin (daptomycin) during her time at Novartis, where she served as VP and global programme head for the company's immunology and ... At Pharmacia, she worked on the anti-infective Zyvox

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

  • SENIOR PHARMA MARKETER JOINS CELLO HEALTH CONSULTING

    He joined the company as Director of Early Phase Commercial Development, before heading up Astellas’ European marketing team for Anti-Infectives.

  • Hayward Medical Communications

    Allergic Disorders. Anaesthetics. Anti-infectives. Cancer/oncology. Cardiovascular. Central nervous system (CNS). Contraception.

  • SEVEN STONES

    Branding. Digital and tech solutions. Exercise co-prescription. Workplace wellbeing. Experience. Anti-infectives, cardiovascular, contrast media, dermatology, diabetes, diagnostics, gastroenterology, gene therapy, health and fitness, hepatology,

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics